Jeffrey Matthew Gryga Irrevocable Trust 13D/13G Filings for Theriva Biologics, Inc. (TOVX)

Jeffrey Matthew Gryga Irrevocable Trust 13D and 13G filings for Theriva Biologics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-11-10
6:03 pm
Purchase
2025-10-2413GTheriva Biologics, Inc.
TOVX
Jeffrey Matthew Gryga Irrevocable Trust739,211
7.700%
739,211increase
(New Position)
Filing